Các bài viết có thể truy cập công khai - Nabil AhmedTìm hiểu thêm
Không có ở bất kỳ nơi nào: 1
Autologous HER2-specific CAR T-cells after lymphodepletion for advanced sarcoma
M Hegde, S Navai, C DeRenzo, S Joseph, K Sanber, MF Wu, K Janeway, ...
Các cơ quan ủy nhiệm: US National Institutes of Health, V Foundation, USA, Cancer Prevention …
Có tại một số nơi: 49
Current concepts in the diagnosis and management of cytokine release syndrome
DW Lee, R Gardner, DL Porter, CU Louis, N Ahmed, M Jensen, SA Grupp, ...
Blood, The Journal of the American Society of Hematology 124 (2), 188-195, 2014
Các cơ quan ủy nhiệm: US National Institutes of Health
Human epidermal growth factor receptor 2 (HER2)–specific chimeric antigen receptor–modified T cells for the immunotherapy of HER2-positive sarcoma
N Ahmed, VS Brawley, M Hegde, C Robertson, A Ghazi, C Gerken, E Liu, ...
Journal of clinical oncology 33 (15), 1688, 2015
Các cơ quan ủy nhiệm: US National Institutes of Health, V Foundation, USA
Her2-specific chimeric antigen receptor–modified virus-specific t cells for progressive glioblastoma: a phase 1 dose-escalation trial
N Ahmed, V Brawley, M Hegde, K Bielamowicz, M Kalra, D Landi, ...
JAMA oncology 3 (8), 1094-1101, 2017
Các cơ quan ủy nhiệm: US National Institutes of Health
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
M Hegde, M Mukherjee, Z Grada, A Pignata, D Landi, SA Navai, ...
The Journal of clinical investigation 126 (8), 3036-3052, 2016
Các cơ quan ủy nhiệm: US National Institutes of Health
TanCAR: a novel bispecific chimeric antigen receptor for cancer immunotherapy
Z Grada, M Hegde, T Byrd, DR Shaffer, A Ghazi, VS Brawley, A Corder, ...
Molecular Therapy-Nucleic Acids 2, e105, 2013
Các cơ quan ủy nhiệm: US National Institutes of Health
Identification of diverse astrocyte populations and their malignant analogs
CCJ Lin, K Yu, A Hatcher, TW Huang, HK Lee, J Carlson, MC Weston, ...
Nature neuroscience 20 (3), 396-405, 2017
Các cơ quan ủy nhiệm: US National Institutes of Health
Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma
K Bielamowicz, K Fousek, TT Byrd, H Samaha, M Mukherjee, N Aware, ...
Neuro-oncology 20 (4), 506-518, 2018
Các cơ quan ủy nhiệm: US National Institutes of Health
HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors
N Ahmed, VS Salsman, Y Kew, D Shaffer, S Powell, YJ Zhang, ...
Clinical cancer research 16 (2), 474-485, 2010
Các cơ quan ủy nhiệm: US National Institutes of Health
Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma
M Hegde, A Corder, KKH Chow, M Mukherjee, A Ashoori, Y Kew, ...
Molecular Therapy 21 (11), 2087-2101, 2013
Các cơ quan ủy nhiệm: US National Institutes of Health
T cells redirected to EphA2 for the immunotherapy of glioblastoma
KKH Chow, S Naik, S Kakarla, VS Brawley, DR Shaffer, Z Yi, N Rainusso, ...
Molecular Therapy 21 (3), 629-637, 2013
Các cơ quan ủy nhiệm: US National Institutes of Health
Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression
N Ahmed, VS Salsman, E Yvon, CU Louis, L Perlaky, WS Wels, ...
Molecular Therapy 17 (10), 1779-1787, 2009
Các cơ quan ủy nhiệm: US National Institutes of Health
Immunogenicity of CAR T cells in cancer therapy
DL Wagner, E Fritsche, MA Pulsipher, N Ahmed, M Hamieh, M Hegde, ...
Nature Reviews Clinical Oncology 18 (6), 379-393, 2021
Các cơ quan ủy nhiệm: US National Institutes of Health
Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma
LK Donovan, A Delaidelli, SK Joseph, K Bielamowicz, K Fousek, ...
Nature medicine 26 (5), 720-731, 2020
Các cơ quan ủy nhiệm: US National Institutes of Health, Canadian Cancer Society, Canadian …
Nanoshell-mediated photothermal therapy improves survival in a murine glioma model
ES Day, PA Thompson, L Zhang, NA Lewinski, N Ahmed, RA Drezek, ...
Journal of neuro-oncology 104 (1), 55-63, 2011
Các cơ quan ủy nhiệm: US National Institutes of Health
PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor
Y Nakazawa, LE Huye, VS Salsman, AM Leen, N Ahmed, L Rollins, ...
Molecular Therapy 19 (12), 2133-2143, 2011
Các cơ quan ủy nhiệm: US National Institutes of Health
CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression
K Fousek, J Watanabe, SK Joseph, A George, X An, TT Byrd, JS Morris, ...
Leukemia 35 (1), 75-89, 2021
Các cơ quan ủy nhiệm: US National Science Foundation, US National Institutes of Health, Cancer …
TEM8/ANTXR1-specific CAR T cells as a targeted therapy for triple-negative breast cancer
TT Byrd, K Fousek, A Pignata, C Szot, H Samaha, S Seaman, ...
Cancer research 78 (2), 489-500, 2018
Các cơ quan ủy nhiệm: US National Institutes of Health
Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma
M Hegde, SK Joseph, F Pashankar, C DeRenzo, K Sanber, S Navai, ...
Nature communications 11 (1), 1-15, 2020
Các cơ quan ủy nhiệm: US National Institutes of Health, V Foundation, USA, Cancer Prevention …
The evolution of T-cell therapies for solid malignancies
K Fousek, N Ahmed
Clinical Cancer Research 21 (15), 3384-3392, 2015
Các cơ quan ủy nhiệm: US National Institutes of Health
Chương trình máy tính sẽ tự động xác định thông tin xuất bản và thông tin về nhà tài trợ